REQUEST A DEMO
Total
USD $0.00
Search more companies

Sri Padmam Biosciences Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Sri Padmam Biosciences Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Sri Padmam Biosciences Private Limited is an enterprise based in India. Its main office is in Chennai. It operates in the Pharmaceutical and Medicine Manufacturing sector. It was first established on May 01, 2006. The company’s latest financial report indicates a net sales revenue drop of 23.53% in 2025. There was a total negative growth of 2.37% in Sri Padmam Biosciences Private Limited’s total assets over the same period. The enterprise’s net profit margin increased by 0.07% in 2025.

Legal Address
Ap 348 1St Floor 29Th Street I Block Kambar Colony Anna Nagar
Chennai; Tamil Nadu; Postal Code: 600040

Contact Details: Purchase the Sri Padmam Biosciences Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Sri Padmam Biosciences Private Limited report to view the information.
Financial Auditors:
Purchase the Sri Padmam Biosciences Private Limited report to view the information.
Incorporation Date:
May 01, 2006
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Sri Padmam Biosciences Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-23.53%
Total Operating Revenue
-24.51%
Operating Profit
-32.29%
EBITDA
-32.42%
Net Profit/Loss for the Period
32.8%
Total Assets
-2.37%
Total Equity
1.61%
Operating Profit Margin
-0.22%
Net Profit Margin
0.07%
Return on Equity (ROE)
0.37%
Debt / Equity
-37.74%
Quick Ratio
0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?